Table 2. Characteristics of patients screened for Candida auris, and national cohort patients, with medical records linked to the Case Mix Programme database, England, 2017–2018.

Patient characteristics	Screened cohorta n = 881		National cohortb,c n = 162,695		p value
	n	%	n	%
Age (years; mean, SD)	59.0	17.7	60.9	18.0	0.001d
Sex
Female	357	40.5	73,050	44.9	0.009
Male	524	59.5	89,645	55.1
Ethnicity
White	561	63.7	143,047	87.9	< 0.001e
Mixed	4	0.5	975	0.6
Asian	145	16.5	6,335	3.9
Black	80	9.1	4,120	2.5
Other	49	5.6	2,409	1.5
Not stated	42	4.8	5,809	3.6
Residency
Non-UK residentf	3	0.3	681	0.4	0.74e
Severe conditions in medical historyg
Severe liver disease	26	3.0	4,413	2.7	0.66e
Very severe cardiovascular disease	25	2.9	2,715	1.7	0.007e
Severe respiratory disease	32	3.7	3,860	2.4	0.014e
End-stage renal failure	56	6.4	3,559	2.2	< 0.001e
Haematological malignancy	34	3.9	3,244	2.0	< 0.001e
Metastatic disease	25	2.9	5,740	3.5	0.27e
Immunocompromised	99	11.3	12,767	7.9	< 0.001e
Prior dependency
Able to live without assistance	623	71.1	123,133	76.0	< 0.001e
Some minor/major assistance	249	28.4	36,976	22.8
Total assistance with all daily activities	4	0.5	1,813	1.1

SD: standard deviation; UK: United Kingdom.

^a 881/921 screened patients had records that were successfully linked to the Case Mix Programme database.

^b These data derive from the Case Mix Programme database. The Case Mix Programme is the national clinical audit of patient outcomes from adult critical care coordinated by the Intensive Care National Audit and Research Centre (ICNARC). For more information on the representativeness and quality of these data, please contact ICNARC (https://www.icnarc.org/).

^c All patients admitted to adult general critical care units between 1 April 2016 and 31 March 2017.

^d t-test.

^e Chi-squared test.

^f Based on 865 patients with a UK postcode or country of residence recorded.

^g Based on 876 patients with evidence available to assess past medical history.